See How McKesson Shares Rise with Money Flows

McKesson (MCK) shares have surged 138.5% since May 2022 and 36% year-to-date, fueled by robust financial performance and significant institutional investor interest. The pharmaceutical distributor reported a strong Q1 FY26, with revenue climbing 23% year-over-year to $97.8 billion, $6.25 EPS, a 15% dividend increase, and raised full-year guidance. This combination of strong fundamentals and sustained 'Big Money' accumulation underscores the company's positive trajectory and potential for continued growth.

Analysis

McKesson Corporation (MCK) is demonstrating a powerful combination of fundamental strength and positive market technicals, driving significant stock price appreciation of 36% year-to-date and 138.5% since May 2022. The company's first-quarter fiscal 2026 results underscore its operational momentum, with revenue growing 23% year-over-year to $97.8 billion and per-share earnings reported at $6.25. Management's confidence is reflected in both a 15% dividend increase to $0.82 per share and raised full-year guidance. This outlook is further substantiated by external estimates predicting a 12.1% increase in EPS for the current year. The article's primary thesis is that this strong fundamental performance is being amplified by significant institutional accumulation, or 'Big Money' inflows. It cites proprietary data identifying 14 'outlier inflow signals' since 2022, suggesting that large investors are actively and heavily buying the stock, providing technical support for the ongoing rally.

Key Decisions for Investors

• Given the convergence of strong revenue growth (+23% YoY), a 15% dividend increase, raised corporate guidance, and data indicating heavy institutional accumulation, the stock's current momentum appears fundamentally supported for a potential long position.
• Investors should closely monitor upcoming earnings reports to ensure the company's performance continues to justify its raised guidance, as sustained execution is critical to supporting the stock's significant 36% year-to-date rally.
• While the reported institutional flows are a strong bullish indicator, it is prudent to assess the stock's current valuation following its 138.5% appreciation since May 2022 to determine if the risk/reward profile remains attractive at the current entry point.